-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632. Chronic Myeloid Leukemia: Therapy: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center)

Ahmad Ghorab, MD, MSc1*, Preetesh Jain, MBBS, MD, DM, PhD1, Hagop M. Kantarjian, MD1, Rashmi Kanagal-Shamanna, MD2, Elias J. Jabbour, MD 3, Koji Sasaki, MD1, Tapan Kadia, MD1, Guillermo Garcia-Manero, MD1, Prithviraj Bose, MD1, Musa Yilmaz, MD1, Kiran Naqvi, MD, MPH1, William G Wierda, MD, PhD1, Srdan Verstovsek, MD, PhD4, Nitin Jain, MD5, Zeev Estrov, MD1, Farhad Ravandi, MBBS6, Susan M. O'Brien, MD7 and Jorge E. Cortes, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
4Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
5Department of Leukemia, MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
7UCI Cancer Center, Orange, CA

Ahmad Ghorab, MD, MSc1*, Hagop M. Kantarjian, MD1, Hesham Elhalawani, MD, MS2*, Hoda Ahmed, MD, MS3*, Ahmed Essam, MD4*, Omar Abdel-Rahman, MD, PhD5*, Elias J. Jabbour, MD 6 and Jorge E. Cortes, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Clinical Oncology Department, Nasser Institute, Cairo, Egypt
4Salam Oncology Center, Cairo, Egypt
5Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
6Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX

Silvia Mori, PhD1*, Philipp D. le Coutre, MD2, Elisabetta Abruzzese, MD3, Bruno Martino4*, Ester Pungolino5*, Chiara Elena6*, Micaela Bergamaschi, MD7*, Sarit Assouline, MD8, Eros Di Bona, MD9*, Antonella Gozzini, MD10*, Marcio Andrade11*, Fabio Stagno, MD, PhD12, Alessandra Iurlo, MD, PhD13*, Michela Luciani14*, Eleonora Parisse14*, Dong-Wook Kim, MD, PhD15, Alessandra Pirola, M.Sc.16*, Michela Viltadi14*, Maria Luisa Bonanomi17*, Patrizia Crivori17*, Rocco Piazza, MD, PhD18* and Carlo Gambacorti-Passerini, MD19

1School of Medicine and Surgery, University of Milano Bicocca, Monza, ITA
2Hematology and Oncology, Charité, Humboldt University, Campus Virchow, Berlin, Berlin, Germany
3Hematology Unit, S.Eugenio Hospital, Tor Vergata University, Rome, ITA
4Hematology Unit, A.O. Bianchi-Melacrino-Morelli, Reggio Calabria, Italy
5Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
6Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
7Division of Hematology 1, IRCCS AOU San Martino-IST, Genova, Italy
8Segal Cancer Center, Lady Davis Institute, McGill University Jewish General Hospital, Montreal, QC, Canada
9Ospedale San Bortolo, UO Hematology, Vicenza, Italy
10SC Terapie Cellulari e Medicina Trasfusionale, AOU Careggi, Florence, Italy
11Hospital Universitario Miguel Servet, Zaragoza, Spain
12Hematology Section, Biomedical Sciences, University of Catania, Trecastagni, ITA
13Hematology Division, IRCCS Cà Granda - Maggiore Policlinico Hospital Foundation, Milano, Italy
14School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
15Catholic Blood and Marrow Transplantation Center, Division of Hematology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
16GalSeq s.r.l, Bresso (MI), Italy
17Clioss s.r.l, Nerviano (MI), Italy
18Dept. of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
19Hematology Unit, ASST-Monza, University of Milano Bicocca, Monza, MB, Italy

Remco J Molenaar1,2*, Tomas Radivoyevitch3*, Aziz Nazha, MD4, Anjali S. Advani, MD5, Aaron T. Gerds, MD, MS6, Jaroslaw P. Maciejewski, PhD, MD, FACP7, Navneet S. Majhail, MD, MS4, Mikkael A. Sekeres, MD, MS8, Matt Kalaycio, MD9 and Sudipto Mukherjee, MD, PhD, MPH5

1Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Academic Medical Center, Amsterdam, Netherlands
3Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
4Taussig Cancer Institute, Department of Hematology & Medical Oncology, Cleveland Clinic, Cleveland, OH
5Leukemia Program, Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
6Cleveland Clinic Foundation, Cleveland, OH
7Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
8Taussig Cancer Institute, Department of Hematology & Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
9Department of Hematology/Oncology, Cleveland Clinic, Cleveland, OH

Lilian Iglesias1, Sudipto Mukherjee, MD, PhD, MPH2, Aziz Nazha, MD3, Anjali S. Advani, MD4, Aaron T. Gerds, MD, MS5, Hetty E. Carraway, MD, MBA3,5, Matt Kalaycio, MD6, Jaroslaw P. Maciejewski, PhD, MD, FACP7, Navneet S. Majhail, MD, MS3 and Mikkael A. Sekeres, MD, MS8

1Case Western Reserve University School of Medicine, Cleveland Heights, OH
2Leukemia Program, Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
3Taussig Cancer Institute, Department of Hematology & Medical Oncology, Cleveland Clinic, Cleveland, OH
4Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
5Department of Hematology/Oncology, Cleveland Clinic, Cleveland, OH
6Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
7Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
8Taussig Cancer Institute, Department of Hematology & Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Sung-Eun Lee, MD1*, Won-Sik Lee, MD, PhD2, Hyeoung-Joon Kim3, Jee Hyun Kong, MD4*, Yunsuk Choi, MD5*, Young Rok Do, MD, PhD6, Jae-Yong Kwak7, Sukjoong Oh, MD, PhD8, Sung-Hyun Kim, MD, PhD9, Jeong-A Kim10, Dae Young Zang11*, Yeung-Chul Mun, MD, PhD12*, Young-Woong Won13* and Dong-Wook Kim, MD, PhD1,14

1Department of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
2Department of Internal Medicine, Inje University College of Medicine, Inje University Busan Paik Hospital, Busan, Korea, Republic of (South)
3Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)
4Department of Hematology Oncology, Wonju College of Medicine, Yonsei University, Wonju, South Korea
5Department of Hematology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, South Korea
6Division of Hematology-Oncology, Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of (South)
7Division of Hematology-Oncology, Chonbuk National University Medical School, Chonbuk National University Hospital, Jeonju, Korea, Republic of (South)
8Division of Hematology-Oncology, School of Medicine, Sungkyunkwan University, Kangbuk Samsung Hospital, Seoul, Korea, Republic of (South)
9Department of Internal Medicine, Dong-A University College of Medicine, Dong-A University Hospital, Busan, Korea, Republic of (South)
10Department of Hematology, The Catholic University of Korea, St. Vincent’s Hospital, Suwon, Korea, Republic of (South)
11Department of Internal Medicine, Hallym University College of Medicine, Hallym University Hospital, Anyang, Korea, Republic of (South)
12Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea, Republic of (South)
13Division of Hematology and Oncology, Hanyang Univerysity College of Medicine, Hanyang University Guri Hospital, Guri, Korea, Republic of (South)
14Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea, Republic of (South)

Martin C. Müller, MD1*, Christian Dietz, PhD1*, Giuseppe Saglio, MD, PhD2, Francois-Xavier Mahon, MD, PhD3, Fabrizio Pane, MD4, Andreas Hochhaus, MD5 and Nicholas C.P. Cross, PhD6

1Institute for Hematology and Oncology (IHO GmbH), Mannheim, Germany
2Department of Clinical and Biological Sciences, University of Turin, Orbassano, Turin, Italy
3Inserm U1035, Bordeaux Segalen University, Bordeaux, France
4Università degli Studi di Napoli, Federico II, Italy
5Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany
6University of Southampton, Salisbury, United Kingdom

Ellen K Ritchie, MD1, Rosalind Catchatourian, MD2, Rebecca B. Klisovic, MD3*, Javier Pinilla Ibarz, MD, PhD4, Michael W. Deininger, MD, PhD5, Harry P. Erba, MD, PhD6, Jerald P. Radich, MD7, Michael R. Savona, MD8, Ilva Dautaj, MS9*, Das Purkayastha9*, Karen Habucky, PhD9 and Michael J. Mauro, MD10

1Weill Cornell Medical College of Cornell University, New York, NY
2Cook County Health and Hospitals System, Chicago, IL
3Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
4H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
5Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
6University of Alabama at Birmingham, Birmingham, AL
7Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
8Vanderbilt-Ingram Center, VUMC, Nashville, TN
9Novartis Pharmaceuticals Corporation, East Hanover, NJ
10Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY

Qian Jiang, MD1, Lu Yu, MD1*, Ya-Zhen Qin1*, Yue-Yun Lai2* and Xiao-Jun Huang, MD3

1Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China
2Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Beijing, China
3Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China

Olivia Copelan, BA1*, Aaron T. Gerds, MD, MS2, Hetty E. Carraway, MD, MBA2, Anjali S. Advani, MD3, Aziz Nazha, MD2, Navneet S. Majhail, MD, MS2, Mikkael A. Sekeres, MD, MS4, Matt Kalaycio, MD5 and Sudipto Mukherjee, MD, PhD, MPH2

1Case Western Reserve University School of Medicine, Columbus, OH
2Taussig Cancer Institute, Department of Hematology & Medical Oncology, Cleveland Clinic, Cleveland, OH
3Leukemia Program, Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
4Taussig Cancer Institute, Department of Hematology & Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
5Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Timothy P. Hughes, MD1, Andreas Hochhaus, MD2, Dong-Wook Kim, MD, PhD3, Francois-Xavier Mahon, MD, PhD4, Francis J. Giles, MD, FRCPI, FRCPath5, Jerald P. Radich, MD6, David M Ross, MBBS, PhD, FRACP, FRCPA7*, Prashanth Gopalakrishna, MD8*, Weiping Deng9*, Rafik Fellague-Chebra, MD10*, Sandip Acharya, MSc11* and Giuseppe Saglio, MD, PhD12

1South Australian Health and Medical Research Institute, SA Pathology, University of Adelaide, Adelaide, Australia
2Abteilung Hämatologie/Onkologie, Universitätsklinikum Jena, Jena, Germany
3Seoul St. Mary's Hospital The Catholic University of Korea, Seoul, South Korea
4Cancer Center of Bordeaux, Institut Bergonié, INSERM U1218, University of Bordeaux, Bordeaux, France
5Northwestern Medicine Developmental Therapeutics Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
6Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
7Haematology and Genetic Pathology, Flinders University, Adelaide, Australia
8Novartis Pharma AG, Basel, Switzerland
9Novartis Pharmaceuticals Corporation, East Hanover, NJ
10Novartis Pharma S.A.S., Rueil-Malmaison, France
11Novartis Health Care Pvt. Ltd., Hyderabad, India
12University of Turin, Orbassano, Torino, Italy

Hanna Grauers Wiktorin, Msc1*, Malin Nilsson, Msc1*, Tina Nilsson, Msc2*, Johan Gustafsson, Msc1*, Ebru Aydin, Msc1*, Anders Ståhlberg, PhD3*, Fredrik B Thoren1*, Kristoffer Hellstrand, MD, PhD1*, Lars Palmqvist, Professor3,4 and Anna Martner, PhD1*

1TIMM Laboratory at Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden
2Department of Clinical Chemistry, University of Gothenburg, Gothenburg, Sweden
3Department of Pathology and Genetics, University of Gothenburg, Gothenburg, Sweden
4Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden

Ali Alahmari, MD1,2*, Jeffrey H. Lipton, MD, PhD3 and Dennis Kim, MD3

1Princess Margaret Cancer Centre, Toronto, ON, Canada
2King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
3Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Rita Assi, MD1*, Hagop M. Kantarjian, MD1, Michael J. Keating, MD1*, Naveen Pemmaraju, MD1, Srdan Verstovsek, MD, PhD2, Guillermo Garcia-Manero, MD1, Farhad Ravandi, MBBS3, Gautam Borthakur, MD1, Jenny Dahl, MS, PA-C4*, Elias J. Jabbour, MD 5 and Jorge E. Cortes, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
3Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
5Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX

Maliha Khan1*, Hagop M. Kantarjian, MD2, Jing Ning, PhD3*, Mary Akosile1*, Wen Li1*, Gautam Borthakur, MD2, Nitin Jain, MD4, Courtney D. DiNardo, MD, MSc5, William G Wierda, MD, PhD2, Farhad Ravandi, MBBS6, Guillermo Garcia-Manero, MD2, Marina Konopleva, MD, PhD7, Tapan Kadia, MD2, Naveen Pemmaraju, MD2, Philip A Thompson, MBBS2*, Naval Daver, MD2, Elias J. Jabbour, MD 8 and Jorge E. Cortes, MD2

1University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
8Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX

Ka-Won Kang, MD1*, Jik-han Jung2*, Woojune Hur3*, Jaena Park4*, Hyunku Shin4*, ByeongHyeon Choi5*, Hyesun Jeong4*, Dae Sik Kim, MD, PhD6*, Eun Sang Yu, MD3*, Se Ryeon Lee, MD, PhD3*, Hwa Jung Sung, MD, PhD3*, Seok Jin Kim, MD, PhD7, Chul Won Choi, MD, PhD3*, Byung Soo Kim, MD, PhD3*, Hyun Koo Kim, MD, PhD5*, Sunghoi Hong, PhD4*, Ji-ho Park, PhD2*, Yeonho Choi, PhD4* and Yong Park, MD, PhD3

1Department of Internal Medicine, Division of Oncology and Hematology, Department of Internal Medicine, Korea University School of Medicine, Seoul 152-703, Korea, Republic of (South)
2Department of Bio and Brain Bioengineering, Korea Advanced Institute of Science and Technology (KAIST), Seoul, Korea, Republic of (South)
3Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea, Republic of (South)
4Korea University, Seoul, Korea, Republic of (South)
5Korea University College of Medicine, Seoul, Korea, Republic of (South)
6Korea University Medical Center, Seoul, Korea, Republic of (South)
7Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)

Laura Cesini1*, Camilla Frieri, MD2*, Claudia Baratè, MD, PhD3*, Federica Sorà, MD4*, Marco Cerrano5*, Antonia Cagnetta, MD6*, Lara Aprile7*, Nicola Sgherza8*, Malgorzata Monika Trawinska9*, Antonella Gozzini, MD10*, Ida Carmosino11*, Federica Ricci, MD12*, Monica Bocchia, MD13*, Micaela Bergamaschi, MD14*, Chiara Aguzzi, MD15*, Simona Sica, MD16*, Sara Galimberti, PhD, MD17*, Massimo Breccia, MD18*, Fabrizio Pane, MD19, Luigiana Luciano20* and Roberto Latagliata21*

1Department of Cellular Biotechnologies and Hematology, University Sapienza of Rome, Roma, ITA
2Hematology, University Federico II of Naples, Neaples, Italy
3Department of Clinical and Experimental Medicine, Section of hematology, University of Pisa, Pisa, Italy
4Institute of Hematology, Catholic University of Rome, Rome, Italy
5Department of Molecular Biothecnologies and Health Sciences, Turin, Italy
6Clinic of Hematology, Department of Internal Medicine (DiMI), Policlinico San Martino, IRCCS per l’Oncologia, University of Genoa, Genoa, Italy
7Hematology, University of Siena, Siena, Italy
8Division of Hematology, IRCCS Ospedale Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
9Division of Hematology, Ospedale S. Eugenio, Roma, ITA
10SC Terapie Cellulari e Medicina Trasfusionale, AOU Careggi, Florence, Italy
11Department of Cellular Biotechnologies and Hematology, University Sapienza of Rome, Rome, Italy
12Hematology, University of Pisa, Pisa, Italy
13Azienda Ospedaliera Universitaria, University of Siena, Siena, Italy
14Division of Hematology 1, IRCCS AOU San Martino-IST, Genova, Italy
15Hematology, University of Turin, Torino, ITA
16Institute of Hematology, Università Cattolica del Sacro Cuore - Policlinico A. Gemelli, Roma, Italy
17Hematology Division, AOUP, Pisa, Italy
18Dipartimento Biotecnologie Cellulari, University of Rome “Sapienza”, Roma, Italy
19Hematology - Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy
20AOU Università degli Studi di Napoli "Federico II", Napoli, Italy
21Department of Cellular Biotechnologies and Hematology, University La Sapienza, Rome, Italy

Ralf Knoefler, MD1*, Falk Eckart1*, Ursula Range2* and Meinolf Suttorp, PhD, MD3

1Department of Pediatric Hemostaseology, Medical Faculty of Technical University Dresden, Dresden, Germany
2Department of Medical Informatics and Biometry, Medical Faculty of Technical University Dresden, Dresden, Germany
3Department of Pediatric Hematology and Oncology, Medical Faculty of Technical University Dresden, Dresden, Germany

Psmh Pakistan Society For Molecular and Clinical Hematology1,2,3,4*, Salman Basit, PhD5*, Abid Jamil, MD PhD6*, Muhammad Absar7*, Anhar Ullah, MS8*, Sibtain Afzal9,10*, Aamer Mahmood, PhD8*, Khushnooda Ramzan, PhD11*, Aamir Aleem12*, Jamil Amjad Hashmi13*, Noor Rehman14*, Khalid Aljamaan15,16*, Saleh Aloraibi15*, Giuseppe Saglio, MD, PhD17,18,19,20, Nawaf Alanazi21,22*, Mudassar Iqbal, MD MS23,24* and Tanveer Akhtar25*

1Pakistan Society for Molecular and Clinical Hematology, Lahore, Pakistan
2Centre for Advanced Molecular Biology, University of the Punjab, Lahore, Pakistan
3Hematology, Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Department of Zoology, University of the Punjab, Lahore, Pakistan
4CAMS-A (College of Applied Medical Sciences Al AHSA) King Saud Bin Abdulaziz University of Health Sciences, National Guard Health Affairs, Al Ahsa, Saudi Arabia
5Centre for Genetics and Inherited Diseases (CGID), Taibah University, Madinah, Saudi Arabia
6Hayatabad Medical Complex, Peshawar, Pakistan
7PhD Student, Hematology, Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group Pakistan & HOPES Laboratory, Department of Zoology, University of the Punjab, Lahore, Pakistan
8College of Medicine & King Khalid University Hospital, King Saud University (CoM KSU), Riyadh, Saudi Arabia
9PhD Fellow, Hematology, Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group Pakistan & HOPES Laboratory, Department of Zoology, University of the Punjab, Lahore, Pakistan
10Immunology Research Chair, College of Medicine & King Khalid University Hospital, King Saud University (CoM KSU), Riyadh, Saudi Arabia
11King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
12Hematology/Oncology (Dept of Medicine), College of Medicine & King Khalid University Hospital, King Saud University (CoM KSU), Riyadh, Saudi Arabia
13Center For Genetics and Inherited Diseases, Madinah, Saudi Arabia
14Department of Pathology, Khyber Medical University, Peshawar, Pakistan
15King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
16Department of Pediatric Hematology/Oncology, King Abdullah Specialist Children Hospital, King Abdulaziz Medical City, Riyadh, Saudi Arabia
17Department of Clinical and Biological Sciences, University of Turin, Orbassano, Turin, Italy
18University of Turin, Dept. of Clinical and Biological Sciences, Orbassano, Italy
19University of Turin, Dept of Clinical and Biological Sciences, Orbassano, Italy
20University of Turin, Orbassano, Torino, Italy
21CAMS-A (College of Applied Medical Sciences Al AHSA) King Saud Bin Abdulaziz University of Health Sciences & King Abdulaziz Hospital, National Guard Health Affairs, Al Ahsa, Saudi Arabia
22Division of Pediatric Hematology /Oncology, Department of Medicine, King Abdulaziz Hospital, National Guard Health Affairs, Al Ahsa, Pakistan
23Asian Medical Institute, Bishkek, Kyrgyzstan
24Hematology, Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group Pakistan & HOPES Laboratory, Department of Zoology, University of the Punjab, Lahore, Pakistan
252Pakistan Society for Molecular and Clinical Hematology, Hematology, Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group Pakistan & HOPES Laboratory, Department of Zoology, University of the Punjab, Lahore, Pakistan

Joanna Gora Tybor1*, Tomasz Sacha2*, Joanna Waclaw2*, Joanna Niesiobedzka-Krezel3*, Olga Grzybowska-Izydorczyk4*, Ewa Medras5*, Izabela Deren-Wagemann5*, Elzbieta Patkowska6*, Ilona Seferynska6*, Krzysztof Lewandowski7*, Anna Wache7*, Beata Blajer-Olszewska8*, Marzena Watek9*, Ewa Wasilewska10*, Tomasz Stoklosa11, Krzysztof Warzocha1* and Krzysztof Jamroziak6*

1Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
2Department of Hematology, Jagiellonian University Hospital, Krakow, Poland
3Department of Hematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
4Medical University of Lodz, Copernicus Memorial Hospital, Łódź, Poland
5Department of Hematology, Blood Cancers and Bone Marrow Transplantation, University Hospital No1, Wrocław, Poland
6Institute of Hematology and Transfusion Medicine, Warsaw, Poland
7Department of Hematology and Stem Cell Transplantation, University of Medical Sciences, Poznan, Poland
8Department of Hematology, Teaching Hospital No 1, Rzeszów, Poland
9Department of Hematology, Holy Cross Oncology Center, Kielce, Poland
10Department of Hematology, Medical University of Białystok, Białystok, Poland
11Medical University of Warsaw, Warsaw, Poland

Nurgul Ozgur Yurttas, MD*, Burak Sarilar, MD*, Ahmet Emre Eskazan, MD, Deniz Ozmen, MD*, Dilek Keskin, MD*, Sevil Sadri, MD*, Selin Berk, MD*, Ayse Salihoglu, MD*, M. Cem Ar, MD, PhD*, Seniz Ongoren, MD*, Zafer Baslar, MD*, Yildiz Aydin, MD* and Teoman Soysal, MD*

Department of Internal Medicine, Division of Hematology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey

Ester Pungolino1*, Mariella D'adda2*, Alessandra Perego, MD3*, Ester Maria Orlandi, MD4*, Mauro Turrini, MD5*, Lorenza Maria Borin, MD6*, Alessandra Iurlo, MD, PhD7*, Salvatore Artale8*, Maria Luisa Latargia, MD9*, Michela Anghilieri, MD10*, Simona Malato, MD11*, Alessandra Trojani12*, Francesco Spina, MD13*, Carraro Maria Cristina, MD14*, Maria Luisa Pioltelli, MD1*, Chiara Elena4*, Cristina Bucelli, MD7*, Pierangelo Spedini, MD15*, Giuseppe Rossi, MD16, Enrica Morra, MD17* and Roberto Cairoli, MD18*

1Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
2Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
3Internal medicine-Hematology, Desio, Italy
4Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
5Valduce Hospital, Dep. of Internal Medicine, Como, Italy
6Department of Hematology, San Gerardo Hospital, Monza, Italy
7Hematology Division, IRCCS Cà Granda - Maggiore Policlinico Hospital Foundation, Milano, Italy
8ASST Valle Olona Sant'Antonio Abate, Gallarate, Italy
9ASST Valle Olona Ospedale di Circolo, Busto Arsizio, Italy
10ASST Lecco, Lecco, Italy
11San Raffaele Scientific Unit, Hematology and Bone Marrow Transplantation Unit, Milano, Italy
12Department of Hematology, Niguarda Hospital, Milano, ITALY, Italy
13Fondazione IRCCS Istituto Tumori, Division of Hematology, Milano, Italy
14Hematology and Transfusion Medicine, ASST Fatebenefratelli Sacco, Milano, Italy
15ASST Cremona, Cremona, Italy
16Department of Hematology, Spedali Civili, Brescia, Italy
17Scientific Coordinator, Lombardi' Hematology Network, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
18ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

Ya-Zhen Qin1*, Stuart Scott2,3*, Dao-Xin Ma4*, Jian-Nong Cen5*, Cong Han6*, Min Xiao, M.D. Ph.D.7*, Jordan Clark8*, Peng Zhao9*, Biao Yin8*, Annie Tapley2*, Debbie Travis2*, Liam Whitby2*, David Barnett2,3* and Xiao-Jun Huang, MD10

1Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China
2UKNEQAS for Leucocyte Immunophenotyping, Sheffield Teaching Hospitals, Sheffield, United Kingdom
3Department of Oncology and Metabolism, Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, United Kingdom
4Department of Hematology, Qilu Hospital of Shandong University, Jinan, China
5Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
6Department of Pathology and Lab Medicine, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
7Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
8Diaceutics, Belfast, United Kingdom
9Novartis Oncology, Beijing, China
10Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China

Juan Manuel Alonso Dominguez, MD, PhD, MSc1*, Rodrigo Iñiguez garcia, MD2*, Susana Olmedillas, PhD3*, Rocio N Salgado, PhD2*, Tamara Castaño, MD3*, Carlos Blas, MD3*, Diego Velasco Rodrgiguez, MD, PhD3*, Gala Vega, MD3*, Jose Luis Lopez Lorenzo, MD2*, Pilar Giraldo, PhD4, Joaquin Martinez Lopez5*, Pilar Llamas, Md PhD6*, Mireia Atance2* and Arantxa Garcías Raso3*

1Hospital Universitario fundacion Jimenez Diaz- IISFJD-UAM, madrid, Spain
2Hospital Universitario fundacion Jimenez Diaz- IISFJD-UAM, Madrid, Spain
3Fundación Jiménez Díaz, Madrid, Spain
4Hospital Quirónsalud Zaragoza, Zaragoza, Spain
5Hospital Universitario 12 de Octubre, Madrid, Spain
6Fundación Jiménez Díaz- IISFJD-UAM, Madrid, Spain

Dragana Milojkovic, MBBS, PhD1*, Richard E. Clark2*, Jennifer L Byrne3*, Brian J.P Huntly4,5*, Manoj Raghavan6*, Farooq A Wandroo7, Sahra Ali8, Belinda Austen9*, Jacqueline Ryan10*, Karsten Friedrich10*, Nicholas C.P. Cross, PhD11 and Adam J Mead, MD, PhD12

1Department of Haematology, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
2Royal Liverpool University Hospitals NHS Trust, Liverpool, GBR
3Centre for Clinical Haematology, Nottingham University Hospitals Trust, Nottingham, GBR
4Cambridge University Hospitals, Cambridge, United Kingdom
5Cambridge Institute for Medical Research, Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom
6University of Birmingham and Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom
7Department of Clinical Haematology, Sandwell & West Birmingham Hospitals NHS Trust, West Bromwich, GBR
8Castle Hill Hospital, Hull, United Kingdom
9Taunton and Somerset NHS Trust, Taunton, GBR
10Novartis Pharmaceuticals UK Limited, Camberley, United Kingdom
11University of Southampton, Salisbury, United Kingdom
12Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

Christopher Gurguis, MS1*, Lizette Rodriguez de Armas2*, Hagop M. Kantarjian, MD1, Prajwal C Boddu, MD1*, Preetesh Jain, MBBS, MD, DM, PhD1, Gautam Borthakur, MD1, Dana Elena Giza2*, Gloria Iliescu, MD3*, Juan Lopez-Mattei2*, Peter Kim2*, Guillermo Garcia-Manero, MD1, Farhad Ravandi, MBBS4, William G Wierda, MD, PhD1, Steven Kornblau, MD1, Elias J. Jabbour, MD 5, Cezar Iliescu, MD2* and Jorge E. Cortes, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX

Jorge E. Cortes, MD1, Stuart L. Goldberg, MD2, Mauricette Michallet, MD, PhD3, Rüdiger Hehlmann, MD4, Bengt Simonsson, MD5*, Michael J. Mauro, MD6, Loretta A. Williams, PhD, MSN, BSN, BA7, Teresa Zyczynski, PharmD, MPH, MBA, BSPharm8*, Ginny P Sen, MPH9*, Aimee Foreman, MA9*, Srikanth Gajavelli, MD8* and Carlo Gambacorti-Passerini, MD10

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Hackensack University Medical Center, Hackensack, NJ
3Hematology department 1 G, Centre Hospitalier Lyon Sud, Pierre Benite, France
4Medizinische Fakultät Mannheim, ELN-Foundation, Weinheim, DEU
5Dept. Hematology, University Hospital, Uppsala, Sweden
6Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY
7MD Anderson Cancer Center, TX, USA, Houston, TX
8Bristol-Myers Squibb, Princeton, NJ
9ICON Clinical Research LLC, South San Francisco, CA
10University Milano Bicocca, San Gerardo Hospital, Monza, Italy

Jorge E. Cortes, MD1, Carlo Gambacorti-Passerini, MD2, Michael W. Deininger, MD, PhD3, Michael J. Mauro, MD4, Charles Chuah, MD5, Dong-Wook Kim, MD, PhD6, Iryna Dyagil, MD PhD7*, Nataliia Glushko8*, Dragana Milojkovic, MBBS, PhD9*, Philipp D. le Coutre, MD10, Valentín García Gutiérrez, PhD11, Laurence Reilly12*, Allison Jeynes-Ellis12*, Rocco J. Crescenzo, DO, FACOI13*, Carla Mamolo14*, Arlene Reisman15*, Nathalie Bardy-Bouxin, PhD16*, Andreas Hochhaus, MD17 and Timothy H. Brümmendorf18

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2University Milano Bicocca, San Gerardo Hospital, Monza, Italy
3University of Utah, Salt Lake City, UT
4Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY
5Singapore General Hospital, Duke-NUS Medical School, Singapore, Singapore
6Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea, Republic of (South)
7Hematology, National Research Center For Radiation Medicine, Kiev, UKR
8National Research Center for Radiation Medicine, Kiev, Ukraine
9Department of Haematology, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
10Charité-Universitätsmedizin Berlin, Berlin, Germany
11Servicio Hematologia y Hemoterapia, Hospital Universitario Ramon y Cajal, Madrid, Spain
12Avillion LLP, London, United Kingdom
13Pfizer, Collegeville, PA
14Pfizer Inc, Groton, CT
15Pfizer Inc, New York, NY
16Global Research and Development, Pfizer International Operation-Oncology, Paris, France
17Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany
18Universitätsklinikum RWTH Aachen, Aachen, Germany

Jorge E. Cortes, MD1, Franck Emmanuel Nicolini, MD, PhD2, Andreas Hochhaus, MD3, Philipp D. le Coutre, MD4, Dong-Wook Kim, MD, PhD5, Javier Pinilla Ibarz, MD, PhD6, Ronald Paquette, MD7, Charles Chuah, MD8, Jane F. Apperley, FRCP, FRCPath, MD, MBChB9, Moshe Talpaz, MD10, Daniel J. DeAngelo, MD, PhD11, Elisabetta Abruzzese, MD, PhD12*, Delphine Rea, MD, PhD13*, Martin C. Mueller, MD14*, Carlo Gambacorti-Passerini, MD15, Fausto Castagnetti, MD16, Stephanie Lustgarten, PhD17*, Frank Neumann, MD, PhD18, Timothy P. Clackson, PhD17, Francois Guilhot, MD19, Michael W. Deininger, MD, PhD20, Timothy P. Hughes, MD, MBBS, FRACP, FRCPA21, Neil P. Shah, MD, PhD22 and Hagop M. Kantarjian, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Centre Hospitalier Lyon Sud, Pierre Bénite & Centre Léon Bérard, Lyon, France
3Jena University Hospital, Jena, Germany
4Charité-Universitätsmedizin Berlin, Berlin, Germany
5Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea,, Seoul, Korea, Republic of (South)
6H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
7Cedars-Sinai Medical Center, Los Angeles, CA
8Singapore General Hospital and Duke-NUS Medical School, Singapore, Singapore
9Centre for Haematology, Imperial College, London, United Kingdom
10Comprehensive Cancer Center, Michigan Medicine, Ann Arbor, MI
11Dana-Farber Cancer Institute, Boston, MA
12S. Eugenio Hospital, Tor Vergata University, Rome, Italy
13Service d'Hématologie adulte et Centre d'Investigation Clinique Hôpital Saint Louis, Paris, France
14Institute for Hematology and Oncology (IHO GmbH), Mannheim, Germany
15University of Milano-Bicocca, San Gerardo Hospital, Monza, Italy
16University of Bologna, Bologna, Italy
17ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
18Takeda Pharmaceutical Company Limited, Cambridge, MA
19Inserm CIC 1402, CHU de Poitiers, Poitiers, France
20Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
21Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
22University of California, San Francisco, San Francisco, CA

Jorge E. Cortes, MD1, Lynn Huynh2*, Estella Mendelson, PhD3*, Patricia Brandt, PhD3*, Darshan Dalal, MPH, MD, PhD3*, Maral Dersarkissian, PhD2*, Diego Cortina, MD, MSc3*, Sahil Narkhede, BA2* and Mei Sheng Duh, MPH, ScD2

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Analysis Group, Inc., Boston, MA
3Novartis Pharmaceuticals Corporation, East Hanover, NJ

David Yeung, PhD, BSc, FRACP, FRCPA, MBBS1,2, Andrew Grigg, MBBS FRACP FRCPA3,4*, Naranie Shanmuganathan, MBBS2,5, Ilona Cunningham, MBBS FRACP FRCPA6,7, Jake Shortt, MBBS PhD FRACP FRCPA8*, Philip Rowling, MBBS FRACP FRCPA9,10*, John Reynolds, PhD11*, Rachel Cushion12*, Rosemary Harrap, MBBS FRACP FRCPA13,14*, David M Ross, MBBS, PhD, FRACP, FRCPA15,16*, David Kipp, MBBS, FRCPA, FRACP17, Anthony K Mills, FRACP, FRCPA, MBBS18, Christopher K Arthur, MD, FRACP, FRCPA, MBBS19,20, Anthony P Schwarer, MD, MBBS (Hons), FRACP, FRCPA21,22, Kathryn Jackson, MBBS FRACP FRCPA23*, Nicholas Viiala, MBBS FRACP FRCPA24,25*, Robert Weinkove, MA, MBBS, PhD, FRCPath, FRACP26, Agnes S. M. Yong, MD, PhD1,2,5, Deborah L White, PhD, FRCPath27,28, Susan Branford, PhD29,30 and Timothy P. Hughes, MD, MBBS, FRACP, FRCPA1,2,5

1Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
2Department of Haematology, SA Pathology, Adelaide, Australia
3Austin Hospital, Melbourne, Australia
4University of Melbourne, Melbourne, Australia
5School of Medicine, University of Adelaide, Adelaide, Australia
6Haematology, Concord Hospital, Concord, Australia
7Sydney Medical School, University of Sydney, Sydney, Australia
8Department of Haematology, Monash Health, Clayton, Australia
9Haematology, Calvary Mater Newcastle Hospital, Waratah, Australia
10School of Medicine and Public Health, University of Newcastle, Newcastle, Australia
11Biostatistics Consulting Platform, Monash University, Melbourne, Australia
12Australasian Leukaemia and Lymphoma Group, Richmond, Australia
13Royal Hobart Hospital, Hobart, Australia
14University of Tasmania, Hobart, Australia
15Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, Australia
16School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, Australia
17University Hospital Geelong, GEELONG, AUS
18Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia
19Department of Haematology, Royal North Shore Hospital, Sydney, Australia
20University of Sydney, Sydney, Australia
21Department of Haematology, Box Hill Hospital, Melbourne, Australia
22The Victorian and Tasmanian Amyloidosis Service, Eastern Health Monash University Clinical School, Melbourne, Australia
23Nambour General Hospital, Birtinya, Australia
24University of NSW, Sydney, Australia
25Liverpool Hospital, Sydney, Australia
26Capital & Coast District Health Board, Wellington, New Zealand
27Cancer Theme, SAHMRI, Adelaide, SA, Australia
28School of Biological Sciences. Faculty of Sciences, University of Adelaide, Adelaide, Australia
29Genetic and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia
30School of Pharmacy and Medical Science, University of South Australia, Department of Genetics and Molecular Pathology, SA Pathology, Centre for Cancer Biology, School of Medicine and School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia

May Garrett1*, Beverly Knight1*, Jorge E. Cortes, MD2 and Michael W. Deininger, MD, PhD3

1Pfizer Oncology, San Diego, CA
2M.D. Anderson Cancer Center, Houston, TX
3University of Utah, Salt Lake City, UT

Gaelle Fossard, MD1*, Vincent Alcazer, MD1*, Marie Balsat, MD1*, Helene Labussiere-Wallet, MD2*, Stephane Morisset, Stat1*, Mohamad Sobh2*, Isabelle Tigaud, MD3*, Pierre Sujobert, MD, PhD4*, Mauricette Michallet, MD, PhD5,6 and Franck Emmanuel Nicolini, MD, PhD2,6,7

1Hematology department, Centre Leon Berard, Lyon, France
2Hematology department 1 G, Centre Hospitalier Lyon Sud, Pierre Benite, France
3Department of Cytogenetics, Lyon-Sud Hospital, LYON, France
4Laboratory of Hematology, Centre Hospitalier Lyon Sud, Pierre Benite, France
5Centre Hospitalier Lyon-Sud, Pierre-Bénite, France
6Fi-LMC group, Pessac, France
7Département d'Hématologie, Centre Leon Berard, Lyon, France

Franck Emmanuel Nicolini, MD, PhD1,2,3, Delphine Rea, MD3, Vincent Alcazer, MD1*, Francoise Huguet, MD3,4*, Laurence Legros, PhD, MD3,5*, Gaelle Fossard, MD1*, Elodie Grockowiak, PhD6*, Stephane Morisset, Stat1*, Pierre Sujobert, MD, PhD7*, Mohamad Sobh2*, Mauricette Michallet, MD, PhD2, Francois Parant, PharmD8* and Marie-Claude Gagnieu, PharmD8*

1Hematology department, Centre Leon Berard, Lyon, France
2Hematology department 1 G, Centre Hospitalier Lyon Sud, Pierre Benite, France
3Fi-LMC group, Pessac, France
4Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
5Hematology department, Centre Hospitalier Universitaire de Nice, Nice, France
6University of Lyon 1, Lyon, France
7Laboratory of Hematology, Centre Hospitalier Lyon Sud, Pierre Benite, France
8Laboratory of Pharmacology, Centre Hospitalier Lyon Sud, Pierre Benite, France

Hsi-Che Liu, MD1, Der-Cherng Liang, MD1, Ting-Chi Yeh, MD1*, Kang-Hsi Wu, MD2*, Jiann-Shiuh Chen, MD3, Tang-Her Jaing, MD4*, Shih-Chung Wang, MD5*, Jiunn-Ming Sheen, MD6*, Chao-Neng Cheng, MD3*, Shih-Hsiang Chen, MD4, Jen-Yin Hou, MD1*, Te-Kau Chang, MD7*, Yuh-Lin Hsieh, MD8*, Fang-Liang Huang, MD7*, Yu-Mei Liao, MD9*, Tsung-Yen Chang, MD4*, Yu-Chieh Chen, MD6*, Tung-Huei Lin, MS10*, Hsiu-Ju Yen, MD11* and Lee-Yung Shih, MD10,12

1Department of Hematology-Oncology, Mackay Children’s Hospital and Mackay Medical College, Taipei, Taiwan
2Division of Pediatric Hematology and Oncology, China Medical University Children's Hospital, Taichung, Taiwan
3Department of Pediatrics, National Cheng Kung University Hospital, Tainan, Taiwan
4Department of Hematology-Oncology, Chang Gung Children’s Hospital–Linkou and Chang Gung University, Taoyuan, Taiwan
5Department of Pediatrics, Changhua Christian Hospital, Changhua, Taiwan
6Department of Pediatrics, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan
7Department of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan
8Department of Pediatrics, Cathay General Hospital, Taipei, Taiwan
9Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
10Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan
11Department of Pediatrics, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan
12Chang Gung University, Taoyuan, Taiwan

Ehab Atallah, MD1, Charles A. Schiffer, MD2, Jerald P. Radich, MD3, Kevin Weinfurt, PhD4*, Mei-Jie Zhang, PhD5*, Vamsi Kota, MBBS6, Javier Pinilla Ibarz, MD, PhD7, Joseph O. Moore, MD8, Richard A. Larson, MD9, Vivian Oehler, MD10, Michael J. Mauro, MD11, Michael W. Deininger, MD, PhD12, James E. Thompson, MD13, Neil P. Shah, MD, PhD14, Martha Wadleigh, MD15, Ellen K Ritchie, MD16, Richard T Silver, MD16, Jorge E. Cortes, MD17, Arielle Baim1*, Mary M. Horowitz, MD, MS18 and Kathryn Flynn, PhD19*

1Medical College of Wisconsin, Milwaukee, WI
2Barbara Ann Karmanos Cancer Inst., Detroit, MI
3Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
4Duke University School of Medicine, Durham
5CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
6Winship Cancer Instiute of Emory University, Atlanta, GA
7H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
8Duke University Medical Center, Durham, NC
9Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
10Fred Hutchinson Cancer Research Ctr., Seattle, WA
11Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY
12University of Utah, Salt Lake City, UT
13Roswell Park Cancer Institute, Buffalo, NY
14University of California, San Francisco, San Francisco, CA
15Dana-Farber Cancer Inst., Boston, MA
16Weill Cornell Medical College, New York, NY
17Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
18CIBMTR, Milwuakee
19Medical College of Wisconsin, Milwuakee

Fumihito Tajima, MD, PhD1, Koji Adachi, MD. PhD.2*, Takaya Nishio, PhD3*, Hiroshi Mochida, MD.4*, Toshio Kawatani, MD, PhD2* and Junji Suzumiya, MD, PhD4*

1Stem cell transplantation Ctr., National Hospital Organization Yonago Med. Ctr., Yonago, Japan
2Stem cell transplantation Ctr., National Hospital Organization Yonago Medical Ctr., Yonago, Japan
3Laboratory Department, National Hospital Organization Yonago Medical Ctr., Yonago, Japan
4Department of Oncology/Hematology, Cancer Ctr., Shimane University, Izumo, Japan

Luigia Luciano, MD1, Giorgina Specchia, MD2, Bruno Martino3*, Vincenzo Accurso, MD4*, Marco Santoro, MD5*, Alessandra Malato, MD6*, Nicola Sgherza7*, Michele Pizzuti, MD8*, Fabio Stagno, MD, PhD9, Pellegrino Musto, MD10*, Attilio Guarini, MD11*, Fiorenza De Gregorio, MD1*, Santina Basile, MD1* and Fabrizio Pane, MD12

1Hematology - Department of Clinical Medicine and Surgery, Federico II University, Napoli, Italy
2U. O. Ematologia con Trapianto – Ambulatorio, Azienda Ospedaliero-Universitaria Policlinico Consorziale di Bari, Bari, Italy
3Azienda Ospedaliera "Bianchi Melacrino Morelli", Reggio Calabria, Italy
4Divisione di Ematologia, A.O.U.P, PALERMO, ITA
5Hematology Unit, Università di Palermo, Palermo, Italy
6UOC di Ematologia con UTMO, Ospedali Riuniti Villa Sofia-Cervello, Palermo, ITA
7Division of Hematology, IRCCS Ospedale Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
8Ematologia, Azieda Ospedaliera S. Carlo, Potenza, Italy
9Chair and Hematology Section, Ferrarotto Hospital, Catania, Italy
10IRCCS CROB, Referral Cancer Center of Basilicata, Rionero In Vulture, ITA
11Hematology Unit – Oncological Department, Istituto Tumori Giovanni Paolo II I.R.C.C.S. Ospedale Oncologico, Bari, Bari, Italy
12Hematology - Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy

Iman Aboudalle, MD1*, Hagop M. Kantarjian, MD2,3, Jan A. Burger, MD, PhD 2, Zeev Estrov, MD4, Maro Ohanian, DO3*, Elias J. Jabbour, MD 5, Srdan Verstovsek, MD, PhD6, Farhad Ravandi, MBBS7, Gautam Borthakur, MD3, Guillermo Garcia-Manero, MD3 and Jorge E. Cortes, MD3

1Leukemia Department, The University of Texas MD Anderson Cancer center, Houston, TX
2Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, University Of Texas, MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
6Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
7Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

Alexis Genthon1*, Franck Emmanuel Nicolini, MD, PhD2,3,4, Marc G. Berger, MD, PhD5*, Sandrine Saugues5*, Alexandre Janel5*, Denis Guyotat6*, Sandrine Hayette, MD7*, Lydia Campos8 and Pascale Flandrin-Gresta, MD8*

1Service d'Hématologie et Thérapie Cellulaire, Institut Lucien Neuwirth, MULHOUSE, France
2Département d'Hématologie, Centre Leon Berard, Lyon, France
3French group of CML, Bordeaux, France
4Centre Hospitalier Lyon Sud, Pierre-Bénite, France
5Service d’Hématologie Biologique and EA 7453 CHELTER, CHU Estaing and Université Clermont Auvergne, Clermont-Ferrand, France
6Département d'Hématologie et Thérapie Cellulaire, Institut Lucien Neuwirth, Saint-Priest-en-Jarez, France
7Lyon-Sud University Hospital, Pierre Bénite, France
8Laboratoire d'Hématologie, CHU de Saint-Etienne, Saint-Priest-en-Jarez, France

*signifies non-member of ASH